Newborn Screening Is on a Collision Course with Public Health Ethics

Area of Science:

• Medical Genetics
• Public Health Policy
• Bioethics

Background:

• Newborn screening (NBS) was founded over 50 years ago based on criteria for serious, urgent, and treatable infant disorders.
• In recent years, NBS has expanded to include conditions not strictly meeting these original criteria.
• Genomic newborn screening is emerging, prompting reevaluation of existing practices and ethical considerations.

Purpose of the Study:

• To examine the evolution of newborn screening criteria.
• To address the ethical issues associated with expanded NBS and proposed genomic NBS.
• To highlight the need for careful consideration of public health implications.

Main Methods:

• Literature review of NBS history and evolution.
• Analysis of current NBS guidelines and recent additions.
• Discussion of ethical frameworks relevant to genetic screening.

Main Results:

• NBS criteria have broadened beyond the original Wilson and Jungner guidelines.
• New and proposed NBS additions present complex public health and ethical challenges.
• Genomic NBS discussions highlight potential benefits and risks.

Conclusions:

• The expansion of NBS necessitates a reevaluation of its foundational principles.
• Ethical considerations are paramount in implementing new screening technologies like genomic NBS.
• Further discourse is required to navigate the public health implications of evolving NBS programs.